Cooper Free Cash Flow 2012-2026 | COO
Cooper annual/quarterly free cash flow history and growth rate from 2012 to 2026. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Cooper free cash flow for the quarter ending April 30, 2026 was 433.70, a year-over-year.
- Cooper free cash flow for the twelve months ending April 30, 2026 was , a year-over-year.
- Cooper annual free cash flow for 2025 was $0.434B, a 50.54% increase from 2024.
- Cooper annual free cash flow for 2024 was $0.288B, a 34% increase from 2023.
- Cooper annual free cash flow for 2023 was $0.215B, a 52.26% decline from 2022.
| Cooper Annual Free Cash Flow | |
|---|---|
| 2025 | 433.70 |
| 2024 | 288.10 |
| 2023 | 215.00 |
| 2022 | 450.40 |
| 2021 | 524.20 |
| 2020 | 176.20 |
| 2019 | 421.10 |
| 2018 | 475.30 |
| 2017 | 466.40 |
| 2016 | 357.00 |
| 2015 | 147.90 |
| 2014 | 216.76 |
| 2013 | 237.80 |
| 2012 | 215.34 |
| 2011 | 232.62 |
| Cooper Quarterly Free Cash Flow | |
|---|---|
| 2025-10-31 | 433.70 |
| 2025-07-31 | 283.80 |
| 2025-04-30 | 119.30 |
| 2025-01-31 | 101.20 |
| 2024-10-31 | 288.10 |
| 2024-07-31 | 160.00 |
| 2024-04-30 | 41.50 |
| 2024-01-31 | 4.60 |
| 2023-10-31 | 215.00 |
| 2023-07-31 | 185.80 |
| 2023-04-30 | 134.20 |
| 2023-01-31 | 83.60 |
| 2022-10-31 | 450.40 |
| 2022-07-31 | 414.60 |
| 2022-04-30 | 197.30 |
| 2022-01-31 | 108.90 |
| 2021-10-31 | 524.20 |
| 2021-07-31 | 414.70 |
| 2021-04-30 | 234.50 |
| 2021-01-31 | 91.80 |
| 2020-10-31 | 176.20 |
| 2020-07-31 | 64.90 |
| 2020-04-30 | -2.80 |
| 2020-01-31 | 60.70 |
| 2019-10-31 | 421.10 |
| 2019-07-31 | 306.00 |
| 2019-04-30 | 184.70 |
| 2019-01-31 | 22.60 |
| 2018-10-31 | 475.30 |
| 2018-07-31 | 282.10 |
| 2018-04-30 | 99.20 |
| 2018-01-31 | -25.20 |
| 2017-10-31 | 466.40 |
| 2017-07-31 | 299.20 |
| 2017-04-30 | 182.80 |
| 2017-01-31 | 79.70 |
| 2016-10-31 | 357.00 |
| 2016-07-31 | 198.90 |
| 2016-04-30 | 101.10 |
| 2016-01-31 | 44.40 |
| 2015-10-31 | 147.90 |
| 2015-07-31 | 101.74 |
| 2015-04-30 | 72.12 |
| 2015-01-31 | 14.85 |
| 2014-10-31 | 216.76 |
| 2014-07-31 | 124.83 |
| 2014-04-30 | 72.73 |
| 2014-01-31 | 7.60 |
| 2013-10-31 | 237.80 |
| 2013-07-31 | 159.52 |
| 2013-04-30 | 95.04 |
| 2013-01-31 | 18.31 |
| 2012-10-31 | 215.34 |
| 2012-07-31 | 133.16 |
| 2012-04-30 | 79.13 |
| 2012-01-31 | 21.60 |
| 2011-10-31 | 232.62 |
| 2011-07-31 | 154.14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $13.894B | $4.092B |
| The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |